Report reveals extent of pharma's role in fighting neglected tropical diseases
A progress report has highlighted how pharma is doing its bit in fighting neglected tropical diseases (NTDs).
The report has been presented by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) to coincide with the World Health Organization’s (WHO) hosting of the Global Partners Meeting on Neglected Tropical Diseases this week, and to mark the fifth anniversary of the WHO’s roadmap on NTDs and the London Declaration pledging a commitment to eradicate these diseases.
The IFPMA’s report, titled Doing our part – Innovating to fight Neglected Tropical Diseases, shows that its member companies are involved in 109 active research and development (R&D) projects for NTDs, of which more than 90% are collaborative involving more than 50 universities, non-governmental organizations and public and private sector institutes.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze